Your browser doesn't support javascript.
loading
Twenty-Year Follow-Up of a Phase II Trial of Taxotere/Carboplatin/Herceptin in Patients With Metastatic HER2-Positive Breast Cancer.
Gomez Marti, Juan Luis; Nasrazadani, Azadeh; Ding, Ying; Normolle, Daniel; Brufsky, Adam M.
Afiliação
  • Gomez Marti JL; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Nasrazadani A; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ding Y; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.
  • Normolle D; Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.
  • Brufsky AM; UPMC Hillman Cancer Center, Department of Medicine, Division of Hematology-Oncology, Magee Women's Hospital, Pittsburgh, PA, USA.
Oncologist ; 28(11): e1123-e1126, 2023 Nov 02.
Article em En | MEDLINE | ID: mdl-37725049
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Observational_studies / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Observational_studies / Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article